Tag: release

ניו יורק, June 18, 2026 (GLOBE NEWSWIRE) --

מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מודיע על תביעה ייצוגית מטעם רוכשי מניות רגילות של Via Transportation, Inc.  (NYSE: VIA) בהתאם ו/או ניתנים לייחס להצהרת הרישום והתשקיף הנלווה (ביחד, "מסמכי ההצעה") שהונפקו בקשר להנפקה הראשונית לציבור של Via ("ההנפקה" או "IPO"). כבר הוגשה תביעה ייצוגית. אם ברצונכם לשמש כתובע המרכזי, עליכם לעתור לבית המשפט עד ולא יאוחר מתאריך 10 באוגוסט 2026. 

LONDON, June 18, 2026 (GLOBE NEWSWIRE) -- Menjelang musim perjalanan musim panas, iFAST Global Bank menghargai pelanggan dengan promosi pulangan tunai 1% untuk masa terhad bagi pembayaran QR yang layak melalui Worldwide Scan & Pay*, meliputi perbelanjaan dalam negara dan luar negara.

MANCHESTER, United Kingdom and OSAKA, Japan, June 18, 2026 (GLOBE NEWSWIRE) -- F2G Ltd and Shionogi & Co., Ltd (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D) (“Shionogi”) today announced positive topline results from the global Phase 3 OASIS study (NCT05101187), comparing the investigational oral antifungal drug olorofim versus AmBisome® (liposomal amphotericin B for injection) followed by standard of care (SOC) in patients with invasive aspergillosis whose infection is either refractory to or unsuitable for azole therapy.

NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- GROWNSY, a baby care innovator trusted by more than 3 million households worldwide, today announced its full Amazon Prime Day 2026 strategy under the campaign theme "Baby Grows. Feeding Grows." This year's Prime Day, confirmed by Amazon as a June event across 26 countries including the United States, United Kingdom, Canada, Germany, France, Italy, and Spain, represents the earliest and most significant mid-year shopping window in the platform's history. GROWNSY is treating it as exactly that: not a routine promotion, but a pivotal moment to meet parents where they are.

Zusammenarbeit zur Prüfung eines Rohstofflogistikzentrums zur Unterstützung des FOAK-Projekts von Aduro im Industriepark Chemelot

Cette collaboration vise à évaluer la mise en place d’un centre logistique de matières premières dans le cadre du projet FOAK d’Aduro au sein du parc industriel de Chemelot

DUBAI, United Arab Emirates, June 18, 2026 (GLOBE NEWSWIRE) --

Pepeto just completed a major upgrade on its exchange in a week where every Ethereum price prediction moved higher, pushing the zero-cost trading engine closer to launch. The presale crossed $10.28 million, and the biggest entries came in while sentiment sat at its lowest point this year, exactly when smaller buyers step back and serious money steps forward. Three live products run, 170% staking APY locks holders in, and the Binance listing is expected before the market catches up.

SINGAPORE, June 17, 2026 (GLOBE NEWSWIRE) -- China's largest international entrepreneurship platform is setting its sights on Singapore, positioning the city-state as its gateway to Southeast Asia. HICOOL 2026 Global Startup Competition wrapped up its Singapore leg on June 4-5 at NUS, drawing nearly 40 teams from China, Singapore, Indonesia, Thailand, Japan, South Korea, India, France, Switzerland, Germany, and beyond. HICOOL has run its Singapore leg for two consecutive years, enabling Singapore's innovation ecosystem and China's industrial landscape to empower each other — creating a genuine two-way flow of technology and markets.

BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced the pricing of an underwritten public offering of 7,700,000 American Depositary Shares (“ADSs”), each representing two ordinary shares of the Company, at a public offering price of $29.35 per ADS. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. All of the ADSs are being offered by Legend Biotech. The gross proceeds to Legend Biotech from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by Legend Biotech, are expected to be approximately $226 million, excluding any proceeds from the exercise of the underwriters’ option to purchase additional ADSs. The offering is expected to close on June 23, 2026, subject to customary closing conditions.